Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
- 1 December 2001
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 38 (7) , 2048-2054
- https://doi.org/10.1016/s0735-1097(01)01671-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cardiovascular effects of endocannabinoids—the plot thickensProstaglandins & Other Lipid Mediators, 2000
- Early Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic ShockNew England Journal of Medicine, 1999
- Platelet‐ and macrophage‐derived endogenous cannabinoids are involved in endotoxin‐induced hypotensionThe FASEB Journal, 1998
- Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shockNature, 1997
- Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptorsBiochemical Pharmacology, 1995
- Novel antagonist implicates the CB1 cannabinoid receptor in the hypotensive action of anandamideEuropean Journal of Pharmacology, 1995
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid ReceptorScience, 1992
- Structure of a cannabinoid receptor and functional expression of the cloned cDNANature, 1990
- Treatment of myocardial infarction in a coronary care unitThe American Journal of Cardiology, 1967